Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty

Journal of the American Academy of Orthopaedic Surgeons

Volumn 17, Issue 3, 2009, Pages 183-196

  Johanson, Norman A ^a   Lachiewicz, Paul F ^b   Lieberman, Jay R ^c   Lotke, Paul A ^d   Parvizi, Javad ^e   Pellegrini, Vincent ^f   Stringer, Theodore A ^g   Tornetta III, Paul ^h   Haralson III, Robert H ⁱ   Watters III, William C ^j  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^e THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^f UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^g STD HIV Colorado Springs   (United States)

^h BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ American Academy of Orthopaedic Surgeons   (United States)

^j Bone and Joint Clinic of Houston   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 62949206399     PISSN: 1067151X     EISSN: None     Source Type: Journal    
DOI: 10.5435/00124635-200903000-00007     Document Type: Review

References (41)

1. Gangireddy C, Rectenwald JR, Upchurch GR, et al: Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vase Surg 2007;45:335-541.
2. Jones T, Ugalde V, Franks P, Zhou H, White RH: Venous thromboembolism after spinal cord injury: Incidence, time course, and associated risk factors in 16,240 adults and children. Arcb pbys Med 2005;86:2240-2247.
3. Knudson MM, Ikossi DG, Khavv I., Morabito D, Speetzen LS: Thromboembolism after ttauma: An analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank. Ann Surg 2004:240: 490-496.
4. Jun ZJ, Ping T. Lei Y, Li L, Ming SY, Jing W: Prevalence of factor V Leiden and prothrombin G202 I OA mutations in Chinese patients with deep venous thrombosis and pulmonary embolism. Clin Lab Haematol 2006;28: 111-116.
5. Wahlander K, Larson C, Lindahl TL, et al: Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery. Thromb Haemost 2002:87:580-585.
6. Imperiale TF, Speroff T: A meta-analysis of methods to prevent venous thromboembolism following total hip replacement. JAMA 1994;271:1780- 1785.
7. Fitzgerald RH Jr, Spiro TE, Trowbridge AA, et al: Prevention of venous thromboembolic disease following primary total knee arthroplasty: A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin. J Bone Joint Surg Am 2001;83:900-906.
8. Hull RD, Pineo GF, Francis C, et al: Low molecular-weight heparin prophylaxis using dalteparin in close proximity to surgety vs warfarin in hip arthroplasty patients: A double-blind, randomized comparison. The North American Fragmin Trial Investigators. Arch Intern Med 2000;160:2199-2207.
9. Turpie AG, Bauer KA, Eriksson BI, Lassen MR, Pentathalon 2000 Study Steering Committee: Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip- replacement surgery: A randomised double-blind trial. Lancet 2002;359: 1721-1726.
10. Lassen MR, Bauer KA, Eriksson BI, Turpie AG, European Pentasaccharide Elective Surgery Study (EPHESUS) Steering Committee: Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip replacement surgery: A randomised double-blind comparison. Lancet 2002; 359:1715-1720.
11. Blanchard J, Meuwly J Y, Leyvraz PF, et al: Prevention of deep-vein thrombosis after total knee replacement: Randomised compatison between a low- molecular-weight heparin (nadroparin) and mechanical prophylaxis with a foot- pump system. J Bone Joint Surg Br 1999; 81:654-659.
12. Pitto RP, Hamer H, Heiss-Dunlop W, Kuehle J: Mechanical prophylaxis of deep-vein thrombosis after total hip replacement a randomised clinical trial. J Bone Joint Surg Br 2004;86:639-642.
13. Warwick D, Harrison J, Whitehouse S, Mitchelmore A, Thornton M: A randomized comparison of a foot pump and low-molecular-weight heparin in the prevention of deep vein thrombosis after total knee replacement. J Bone Joint Surg Br 2002;84:344-350.
14. Welsby IJ, Podgoreanu MV, Phillips-Bute B, et al: Genetic factors contribute to bleeding after cardiac surgery. J Thromh Haemost 2005;3:1206-1212.
15. Segal JB, Streiff MB, Hoffman LV, Thornton K, Bass FB: Management of venous thromboembolism: A systematic review for a practice guideline. Ann Intern Med 2007;146:211-222.
16. Salvati EA, Pellegrini VD Jr, Sharrock NE, et al: Recent advances in venous thromboembolic prophylaxis during and after total hip replacement. J Bone joint Surg Am 2000;82:252-270.
17. Sharrock NE, Go G, Harpel PC, Ranawat CS, Sculco TP, Salvati EA: The John Charnley Award: Thrombogenesis during total hip arthroplasty. Clin Orthop Relat Res 1995;319:16-27.
18. Hooker JA, Lachiewicz PF, Kelley SS: Efficacy of prophylaxis against thromboembolism with intermittent pneumatic compression after primary and revision total hip arthroplasty. J Bone Joint Surg Am 1999;81:690-696.
19. Lachiewicz PF, Soileau ES: Multimodal prophylaxis for THA with mechanical compression. Clin Orthop Relat Res 2006;453:225-230.
20. Woolson ST: Intermittent pneumatic compression prophylaxis for proximal deep venous thrombosis after total hip replacement. J Bone Joint Surg Am 1996;78:1735-1740.
21. Ryan MG, Westrich GH, Potter HG, et al: Effect of mechanical compression on the prevalence of proximal deep venous thrombosis as assessed by magnetic resonance venography. J Bone Joint Surg Am 2002;84:1 998-2004.
22. Westrich GH, Specht LM, Sharrock NE, et al: Pneumatic compression hemodynamics in total hip arthroplasty. Clin Orthop Relat Res 2000;372:180-191.
23. Lachiewicz PF, Kelley SS, Haden I.R: Two mechanical devices for prophylaxis of thromboembolism after total knee arthroplasty: A prospective, randomised study. J Bone Joint Surg Br 2004;86: 1137-1141.
24. Lotke PA, L.onner JH: The benefit of aspirin chemoprophylaxis for thromboembolism after total knee arthroplasty. Clin Orthop Relat Res 2006;452:175-180.
25. Silbersack Y, Taute BM, Hein W, Podhaisky H: Prevention of deep-vein thrombosis after total hip and knee replacement: Low-molecular-weight hepatin in combination with intermittent pneumatic compression. J Bone Joint Surg Br 2004;86:809-812.
26. Westrich GH, Bottner F, Windsor RE, Laskin RS, Haas SB, Sculco TP: VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. J Arthroplasty 2006;21(6 suppl 2)139- 143.
27. Lieberman JR, Hue MM, Hanway J, Salvati EA, Sculco TP, Sharrock NE: The prevalence of deep venous thrombosis after total hip arthroplasty with hypotensive epidural anesthesia. J Bone Joint Surg Am 1994;76:341-348.
28. Prins MH, Hirsh J: A comparison of general anesthesia and regional anesthesia as a risk factor for deep vein thrombosis following hip surgery: A critical review. Thromb Haemost 1990; 64:497-500.
29. Levine MN, Raskob G, Beyth RJ, Kearon C, Schulman S: Hemorrhagic complications of anticoagulant treatment: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 287S-310S.
30. Howie C, Hughes H, Watts AC: Venous thromboembolism associated with hip and knee replacement over a ten-year period: A population-based study. J Bone joint Surg Br 2005;87:1675-1680.
31. Bjornara BT, Gudmundsen TE, Dahl OE: Frequency and timing of clinical venous thromboembolism after major joint surgery. J Bone joint Surg Br 2006; 88:386-391.
32. Johnson R, Green JR, Charnley J: Pulmonary embolism and its prophylaxis following the Charnley total hip replacement. Clin Orthop Relat Res 1977;127:123-132.
33. Phillips CB, Batrett JA, Losina E, et al: Incidence rates of dislocation, pulmonary embolism, and deep infection during the first six months after elective total hip teplacement. J Bone Joint Surg Am 2003;85-A:20-26.
34. Williams O, Fitzpatrick R, Hajat S, et al: Mortality, morbidity, and I-year outcomes of primary elective total hip arthroplasty. J Arthroplasty 2002; I 7: 165-171.
35. Heit JA, Elliott CG, Trowbridge AA, Morrey BF, Gent M, Hirsh j: Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip 34 ot knee replacement: A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2000;132:853-861.
36. Colwell CW Jr, Collis DK, Paulson R, et al: Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty: Evaluation during hospitalization and three months after discharge. J Bone Joint Surg Am 1999; 81:932-940.
37. Francis CW, Pellegrini VD Jr, Totterman S, et al: Prevention of deep-vein thrombosis after total hip arthroplasty: Comparison of warfarin and dalteparin. J Bone joint Surg Am 1997;79:1.365- 1372.
38. Freedman KB, Brookenthal KR, Fitzgerald RH Jr, Williams S, Lonner JH: A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg Am 2000; 82-A:929-938.
39. Dalldorf PG, Perkins FM, Totterman S, Pellegrini VD Jr: Deep venous thrombosis following total hip arthroplasty: Fffeets of prolonged postoperative epidutal anesthesia. J Arthroplasty 1994;9:611-616.
40. Pellegrini VD, Donaldson CT, Farber DC, Lehman EB, McColltster Evarts C: Prevention of readmission for venous thromboembolism alter total knee arthroplasty. Clin Orthop Relat Res 2006;452:21-27.
41. Pellegrini VD Jr, Donaldson CI, barber DC, Lehman EB, Evarts CM: The John Charnley Award: Prevention of readmission for venous thromboembolic disease after total hip arthroplasty. Clin Orthop Relat Res 2005;441:56-62.